Novartis AG
SIX:NOVN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
SIX:NOVN
|
CH |
|
E
|
Eli Lilly and Co
F:LLY
|
US |
|
Barrick Mining Corp
F:ABR0
|
CA |
|
S
|
Super Group Ltd
JSE:SPG
|
ZA |
|
B
|
Brookfield Asset Management Inc
XBER:BKAA
|
CA |
|
Siriuspoint Ltd
NYSE:SPNT
|
BM |
Wall St Price Targets
NOVN Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOVN is 125.27 CHF with a low forecast of 95.95 CHF and a high forecast of 147 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOVN's stock price target?
Price Target
125.27
CHF
According to Wall Street analysts, the average 1-year price target for NOVN is 125.27 CHF with a low forecast of 95.95 CHF and a high forecast of 147 CHF.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 7%.
